The Impact of Vaccination and SARS-CoV-2 Variants on the Virological Response to SARS-CoV-2 Infections during the Alpha, Delta, and Omicron waves in England

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

(2022) Catherine J. Reynolds et al.   SCIENCE

SARS Antibody Testing in Children: Development of Oral Fluid Assays for IgG Measurements

(2022) Katja Hoschler et al.   Microbiology Spectrum

Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study

(2022) Maylis Layan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Mapping of SARS-CoV-2 IgM and IgG in gingival crevicular fluid: antibody dynamics and linkage to severity of COVID-19 in hospital inpatients

(2022) Samreen Ijaz et al.   JOURNAL OF INFECTION

Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2

(2022) Olha Puhach et al.   NATURE MEDICINE

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2

(2022) Michela Antonelli et al.   LANCET

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

(2022) Kerstin Kläser et al.   Scientific Reports

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience

(2022) Elise Tessier et al.   INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England

(2022) Freja Cordelia Møller Kirsebom et al.   Nature Communications

The spike gene target failure (SGTF) genomic signature is highly accurate for the identification of Alpha and Omicron SARS-CoV-2 variants

(2022) Tracy McMillen et al.   Scientific Reports

Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study

(2022) James A Hay et al.   eLife

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

(2021) Matan Levine-Tiefenbrun et al.   NATURE MEDICINE

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

(2021) Michela Antonelli et al.   LANCET INFECTIOUS DISEASES

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

(2021) Jamie Lopez Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

(2021) Mark G. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19

(2021) Paul Z Chen et al.   eLife

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study

(2021) Po Ying Chia et al.   CLINICAL MICROBIOLOGY AND INFECTION

Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study

(2021) Raphael Sonabend et al.   LANCET

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study

(2021) Anika Singanayagam et al.   LANCET INFECTIOUS DISEASES

Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series

(2020) Merle M Böhmer et al.   LANCET INFECTIOUS DISEASES

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020

(2020) Anika Singanayagam et al.   Eurosurveillance